4\ SaEmPasAa Roney en \ EET PFOA & FACT PFOS DSrHi.EnEkTing Water Health Advisories BL | EP nas established health advisories for PFOA and PFOS based on the aat |} ||o waagteencrys'ysstaesmsesospemreanttoorfs,tahendlsattaetste,petreirb-arleavnidewleodcaslcoifefniccealtsowphroovihdaevedrtihneking wil o: g hB) tphreimhaerayltrhesipsoknssiobfiltihteysfeorchoevmeircsaelesi,ngsothtehseey csyasntteamkse, twhiethapipnrfooprrmiaattieonacotnions.

sf CAORM2P2AN6Y-1SA0N4I4TIZED Telomer Research Program Update and Status Report United States Environmental Protection Agency 18 December 2001 2 8 on z 33 z 3 s 33 = rime tre Comyn rrr \ Agenda + TRP General Update; TRP Meetings Radio-label Update + Pharmacokinetics Toxicology & Descriptive Biology Environmental Fat&e Effects + Summary Discussion and Path Forward teetarpm comp rtsgto g 2 SR o ZZ a8 5 2 Company Sanitize..

s5ke5m0 << AR 226 -- 1181 4 ( RECE:VE OMAYf1fe4 pc200eonifcs Cl1ar3i5es6tHoann,sWfoYr,d 2S5e30t1 (304) 5(5380.69)1$6508T-e4l2e5p5haFnaex West Virginia Department of Environmental Protection S Gover we -- TS T waCaS0 elcgey Robert A.

A DIETARY LCS0 STUDY WIpTrOHS:THE NORTHERN BOBWHITE Ar226 _0953 ALiT SN WILDLIFE INT3EMRLNAABTIROENQAULESLTTD.NO:PROUJ2E7C23T NO.: 454-103 Series 8U3S0.- EEncvoliorgoincmaelntEfaflecPtrsotTeecsttioGnuiAdgeelnicneys (draft) `OPPTS Number 850.2200 FIFRA Subdivision E, Section 71-2 OECD Guideline 205 . 3 2 23 T4 3S2E zE358% = AUTHORS: CSoeuarntPn.eyGaSl.laCgahseery JRoaaynmnoBn.dBLe.avVearns Hoven I STUDY COMPLETION: April 26,2000 SUBMITTED TO .

Monsa 'o MONSANTO COMPANY ST.

1 MONTANA TENTH JUDICIAL DISTRICT COURT, FERGUS COUNTY 2 3 MARTY PAULSON, WILLIAM J. ) HAUGEN, HARRY FELTON,RAY ) 4 ROBINSON AND WARD BURLEIGH, ) PRESIDENT: BURLEIGH ANGUS ) 5 RANCH, INC., INDIVIDUALLY ) AND FOR ALL PERSONS ) 6 SIMILARLY SITUATED, ) ) 7 PLAINTIFFS, ) ) CAUSE NO.

CO 220 hto Rm Monsanto J/1Y4 SHIPPER'S NO.

*. , rc*T(oN.i<,W.

DVERSARYPROCEEDING COVER SHEET (Instruclions on Reverse) ADVERSARY PROCEEDING NUMBER (Court Use 0 nly) THIRD-PARTY PLAINTIFF Armstrong World Industries, Inc.

1 In Re: 2 Solutia, et al., 3 4 Vs.

1 2 IN THE SUPERIOR COURT OF THE STATE OF ARIZONA IN AND FOR THE COUNTY OF MARICOPA 3 Case No.

1 NO. 03-CV-0801 2 RICK MONTALBANO, ET AL

file:///C|/Users/MadeK42/Desktop/whysner-upload/10-27-08%20AM.txt 3851 1 CASE NUMBER: BC 367800 2 CASE NAME: WILLIAM MOLINA AND ANGELINA MOLINA 3 VS. 4 SHELL OIL COMPANY, ET AL. 5 LOS ANGELES, CA MONDAY, OCTOBER 27, 2008 6 DEPT.

Graft outcome Bone Marrow Transplantation (2001) 27, 10371043 2001 Nature Publishing Group All rights reserved 02683369/01 $15.00 www.nature.com/bmt Impact of complete remission with intensive therapy in patients with responsive multiple myeloma R Alexanian, D Weber, S Giralt, M Dimopoulos, K Delasalle, T Smith and R Champlin University of Texas MD Anderson Cancer Center, Houston, Texas, USA Summary: Clinical outcomes were assessed in 68 consecutive patients with multiple myeloma of high or intermediate tumor mass that had responded to VAD or dexamethasone-based therapy and were consolidated with early intensive therapy and autologous stem cell transplantation.

Epigenetics and environmental chemicals Andrea Baccarelli and Valentina Bollati Laboratory of Environmental Epigenetics, Center of Molecular and Genetic Epidemiology, Department of Environmental and Occupational Health, University of Milan and IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan, Italy Correspondence to Andrea Baccarelli, MD, PhD, Center of Molecular and Genetic Epidemiology, Department of Environmental and Occupational Health, University of Milan and IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Via San Barnaba 8, 20122 Milan, Italy Tel: +39 02 503 20145; fax: +39 02 503 20103; e-mail: andrea.baccarelli@unimi.it Current Opinion in Pediatrics 2009, 21:243251 Purpose of review Epigenetics investigates heritable changes in gene expression occurring without changes in DNA sequence.